ENTA
Enanta Pharmaceuticals Inc
Price:  
7.70 
USD
Volume:  
135,156.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA Relative Valuation

-1098.6%
Upside

As of 2025-07-02, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (76.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.70 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -1098.6%.

The range of the Relative Valuation is (65.03) - (87.49) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.0x - 23.6x 18.0x
Forward P/E multiples 14.4x - 19.4x 16.1x
Fair Price (65.03) - (87.49) (76.89)
Upside -944.5% - -1236.2% -1098.6%
7.70 USD
Stock Price
(76.89) USD
Fair Price

ENTA Relative Valuation - Historical P/E Data

Date P/E
2025-07-02 -1.79
2025-07-01 -1.71
2025-06-30 -1.68
2025-06-27 -1.66
2025-06-26 -1.67
2025-06-25 -1.65
2025-06-24 -1.62
2025-06-23 -1.58
2025-06-20 -1.59
2025-06-18 -1.60
2025-06-17 -1.56
2025-06-16 -1.61
2025-06-13 -1.66
2025-06-12 -1.64
2025-06-11 -1.76
2025-06-10 -1.68
2025-06-09 -1.66
2025-06-06 -1.66
2025-06-05 -1.60
2025-06-04 -1.58
2025-06-03 -1.59
2025-06-02 -1.39
2025-05-30 -1.31
2025-05-29 -1.37
2025-05-28 -1.30
2025-05-27 -1.29
2025-05-23 -1.29
2025-05-22 -1.28
2025-05-21 -1.28
2025-05-20 -1.35
2025-05-19 -1.32
2025-05-16 -1.28
2025-05-15 -1.19
2025-05-14 -1.15
2025-05-13 -1.16
2025-05-12 -1.23
2025-05-09 -1.17
2025-05-08 -1.18
2025-05-07 -1.12
2025-05-06 -1.12
2025-05-05 -1.21
2025-05-02 -1.32
2025-05-01 -1.34
2025-04-30 -1.35
2025-04-29 -1.28
2025-04-28 -1.25
2025-04-25 -1.24
2025-04-24 -1.26
2025-04-23 -1.24
2025-04-22 -1.22